e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Clinical asthma: miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prescription rates for various classes of COPD & asthma medication in Turkey
A. Utkusavas, C. Cuhadaroglu, M. Erelel, E. Kiyan, O. Arseven, Z. Kilicaslan, F. K. Erkan, T. Ece, L. Tabak (Istanbul, Turkey)
Source:
Annual Congress 2001 - Clinical asthma: miscellaneous
Session:
Clinical asthma: miscellaneous
Session type:
Thematic Poster Session
Number:
2868
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Utkusavas, C. Cuhadaroglu, M. Erelel, E. Kiyan, O. Arseven, Z. Kilicaslan, F. K. Erkan, T. Ece, L. Tabak (Istanbul, Turkey). Prescription rates for various classes of COPD & asthma medication in Turkey. Eur Respir J 2001; 16: Suppl. 31, 2868
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Statin use and risk of exacerbations in individuals with COPD: The Copenhagen general population study
Source: International Congress 2014 – New insights into the epidemiology of COPD
Year: 2014
Costs of COPD and asthma in Sweden
Source: Eur Respir J 2004; 24: Suppl. 48, 701s
Year: 2004
Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Real-world medication use patterns in stable COPD patients from Romania
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014
Differences in adherence to common inhaled medications in COPD
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Comparing pharmacist time use for asthma and COPD patients using various types of inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Changes in demographics and asthma characteristics of the hospitalized asthma exacerbations in Barcelona in the 2000 decade
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Hospital readmissions and social deprivation in asthma and COPD
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Antibiotics prescriptions increased medical costs for COPD exacerbations.
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Medication use in multi-symptom asthma: Results from the West Sweden asthma study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Difference between asthma and COPD patients in adherence and non-adherence patterns to inhaler devices
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Cost of asthma in patients treated with national asthma guideline in Turkey
Source: Eur Respir J 2003; 22: Suppl. 45, 481s
Year: 2003
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept